No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ELYM Eliem Therapeutics
- 8.320
- +1.020+13.97%
Close Jul 22 16:00 ET
- 8.330
- +0.010+0.12%
Pre 08:43 ET
555.65MMarket Cap-16000P/E (TTM)
8.350High7.515Low959.44KVolume7.750Open7.300Pre Close7.71MTurnover3.71%Turnover RatioLossP/E (Static)66.79MShares11.55052wk High5.22P/B214.95MFloat Cap2.35052wk Low--Dividend TTM25.84MShs Float29.690Historical High--Div YieldTTM11.44%Amplitude2.210Historical Low8.037Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Eliem Therapeutics Insider Sold Shares Worth $289,492, According to a Recent SEC Filing
EVP, R&D AND CSO Valerie Morisset Sells 50,000 Shares of Eliem Therapeutics Inc (ELYM)
Insider Sale at Eliem Therapeutics Inc (ELYM): EVP, R&D AND CSO Valerie Morisset Sells ...
Express News | Eliem Therapeutics Files Prospectus Relates To Resale From Time To Time Of Up To 36.8M Shares Of Common Stock By Selling Stockholders
Express News | Eliem Therapeutics - Files Prospectus Relates to Resale From Time to Time of up to 36.8 Mln Shares of Common Stock by Selling Stockholders
Comments
$Eliem Therapeutics(ELYM.US$
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
Eliem Therapeutics has completed its acquisition of Tenet Medicines and a concurrent $120 million private placement. The company plans to advance TNT119, an anti-CD19 antibody aimed at treating various autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. With the acquisition, Eli...
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
Eliem Therapeutics has completed its acquisition of Tenet Medicines and a concurrent $120 million private placement. The company plans to advance TNT119, an anti-CD19 antibody aimed at treating various autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. With the acquisition, Eli...
1
Keep an eye on these M&As: 👀
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt(ADTX.US$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics(KTRA.US$
$Johnson & Johnson(JNJ.US$ to acquire $ShockWave Medical(SWAV.US$
$Vertex Pharmaceuticals(VRTX.US$ to acquire $Alpine Immune(ALPN.US$
$Century Therapeutics(IPSC.US$ to acquire Clade Tx
$Eliem Therapeutics(ELYM.US$ to acquire Tenet Med.
$Incyte(INCY.US$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals(DCPH.US$
...
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt(ADTX.US$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics(KTRA.US$
$Johnson & Johnson(JNJ.US$ to acquire $ShockWave Medical(SWAV.US$
$Vertex Pharmaceuticals(VRTX.US$ to acquire $Alpine Immune(ALPN.US$
$Century Therapeutics(IPSC.US$ to acquire Clade Tx
$Eliem Therapeutics(ELYM.US$ to acquire Tenet Med.
$Incyte(INCY.US$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals(DCPH.US$
...
7
Eliem Therapeutics Acquires Tenet Medicines: A Landmark Deal in the Biopharma Sector.
In an ambitious move that is set to redefine the landscape of the biopharmaceutical industry, Eliem Therapeutics, Inc. has officially announced its agreement to acquire Tenet Medicines, Inc. Alongside this acquisition, Eliem has also unveiled plans for a concurrent $120 million private placement, marking a significant financial investme...
In an ambitious move that is set to redefine the landscape of the biopharmaceutical industry, Eliem Therapeutics, Inc. has officially announced its agreement to acquire Tenet Medicines, Inc. Alongside this acquisition, Eliem has also unveiled plans for a concurrent $120 million private placement, marking a significant financial investme...
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
